肺移植的区域镇痛:叙述性综述
肺移植是终末期肺病的确定性治疗,全球每年约完成4500例。由于病因、手术方式和体外生命支持使用的多样性,标准化镇痛方案具有挑战性。胸段硬膜外镇痛常被视为金标准,但安全性担忧促使人们探索胸神经阻滞等更安全的镇痛方式。胸神经阻滞在普通胸外科的优势已确立,但在肺移植中的效用尚不明确;本文旨在提高对该领域文献空白的认识,并强调需要高质量研究来确定现有技术的有效性。
要点
- 肺移植镇痛需兼顾舒适、早期活动和预防肺部并发症。
- 胸段硬膜外镇痛常被视为金标准,但存在安全性担忧。
- 胸神经阻滞在肺移植中的效用尚不明确,需进一步研究。
核心结论
- 肺移植区域镇痛领域存在文献空白,胸神经阻滞等技术的有效性需高质量研究确定。
研究设计与样本
- 叙述性综述,未报告系统检索范围与样本量。
主要发现
- 全球每年约完成4500例肺移植,麻醉与疼痛管理具有挑战性。
- 胸段硬膜外镇痛常被视为金标准,但安全性担忧促使寻求更安全的镇痛方式。
- 胸神经阻滞在普通胸外科的优势已确立,但在肺移植中的效用尚不明确。
临床怎么用
- 临床需根据病因、手术方式和体外生命支持使用情况个体化选择镇痛方案。
- 在肺移植中应用胸神经阻滞时,应认识到其有效性证据尚不充分。
局限性
- 相关文献匮乏,本综述为叙述性,未提供系统评价或定量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung transplantation (LTx) is the definitive treatment for end-stage pulmonary disease. About 4500 LTxs are performed annually worldwide. It is considered challenging and complex surgery regarding anaesthesia and pain management. While providing adequate analgesia is crucial for patient comfort, early mobilisation and prevention of postoperative pulmonary complications, standardising an analgesic protocol is challenging due to the diversity of aetiologies, surgical approaches and the potential use of extracorporeal life support (ECLS). Although thoracic epidural analgesia is commonly considered the gold standard, concerns regarding procedural safety and its potential for devastating consequences have led physicians to seek safer analgesic modalities such as thoracic nerve blocks. The advantages of thoracic nerve blocks for general thoracic surgery are well established. However, their utility in LTx remains unclear. Considering paucity of relevant literature, this review aims to raise awareness about the literature gap in the field and highlight the need for further high-quality studies determining the effectiveness of available techniques.
引用
- Azem K, Mangoubi E, Zribi B, et al. Regional analgesia for lung transplantation: A narrative review. Eur J Anaesthesiol. 2023. PMID: 37232676. doi:10.1097/EJA.0000000000001858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。